The American Association of Nurse Practitioners® (AANP) is committed to providing members with up-to-date clinical and policy resources and information related to the COVID-19 pandemic and National Emergency Declaration.
Human-to-human transmission has now been confirmed in China and other countries around the world, including within the U.S. WHO has released daily situation reports monitoring the spread, treatment recommendations and response to the outbreak. It also maintains an updated situation dashboard on COVID-19 cases globally and reports that there have been 62,844,837 confirmed cases and 1,465,144 confirmed deaths worldwide.
The CDC reports that there have been 13,447,627 total cases and 267,302 deaths in the U.S. All states are reporting community spread of COVID-19.
The United States Census Bureau has created a dashboard to show states' COVID-19 impact planning reports, nationwide demographic and economic analysis and additional data on how the pandemic is impacting communities and Americans across the U.S.
The CDC currently recommends wearing cloth face coverings in public settings where other social distancing measures are difficult to maintain and especially within areas that are seeing significant community-based transmission.
The CDC has released interim guidance for health care professionals in the U.S. to combat the spread of this illness, including but not limited to guidance on:
As of December 1, 190,944,656 tests have been reported, according to the CDC, with 15,072,955 reported as positive.
On March 16, President Trump announced COVID-19 guidelines for the U.S., which were extended through April 30.
The White House has since released Guidelines for Opening Up America Again. These include necessary criteria before states begin their phased openings, what states need to do to prepare to open and guidelines for each phase of opening.
The White House released its COVID-19 Vaccine Distribution Strategy, which includes two documents detailing the distribution strategy and a vaccine program interim playbook.
The U.S. Department of Health and Human Services (HHS) has produced a video series detailing the history and science of vaccines. The series is designed to provide background and clarity — via expert commentary and graphic illustration — to help viewers understand how vaccines are developed and the full strength of initiatives such as Operation Warp Speed.
NAM and the American Public Health Association have launched a nonaccredited webinar series to explore the current science about COVID-19. Webinar topics include crisis standards of care during COVID-19, the science behind social distancing and the impact of COVID-19 on long-term health.
A NAM committee has also reviewed the effectiveness of homemade fabric masks, potential effects of seasonal and temperature changes and how infected patients spread COVID-19. The committee was assembled in March at the request of the U.S. Department of Health and Human Services.
To address health disparities, particularly brought to light during the COVID-19 pandemic, the National Quality Forum has released The Care We Need, a roadmap to normalize high-quality health care for every person by 2030. The report focuses on opportunities to improve the health outcomes of people and communities, along with recommendations that emphasize the importance of a seamless system of comprehensive, accessible care designed to keep people healthy and well.
PCORI has produced a six-part, nonaccredited webinar series on COVID-19, available at no cost. Topics in the series include how incident command structures can be utilized to coordinate a response to COVID-19, nurse staffing practices and issues and the changing role of telehealth.
In partnership with the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) and in collaboration with the National Ebola and Special Pathogens Training and Education Centers (NETEC), Project ECHO has launched a series of COVID-19 Clinical Rounds. These panel discussions are designed to facilitate learning and dialog concerning COVID-19 treatment, and a number of special sessions highlight topics such as pediatrics, personal protective equipment (PPE), long-term care facilities and more.
AANP is closely tracking policy developments in response to the COVID-19 pandemic.
AANP is committed to keeping you up to date, including by providing details on federal- and state-issued waivers and flexibilities for NPs and increased access to telehealth. Information included is related to Centers for Medicare and Medicaid Services (CMS) waivers, emergency state actions and licensure information and other policy guidance.
AANP conducted two surveys on the impact of COVID-19 on NPs.
AANP is compiling educational and clinical information regarding the COVID-19 pandemic, including a look at symptoms, testing, infection control, protection for health care providers and current, approved treatment options and investigational treatments. When available, information on funding and research is also shared.
Three patient education infographics, designed to provide information on common symptoms and tips on protecting oneself and others from COVID-19, are now available for download.
The first cases of the novel (new) coronavirus were reported in Wuhan, China, in December 2019. Describing a respiratory illness with symptoms of fever, cough and shortness of breath, COVID-19 is different than coronaviruses that are already known to circulate among humans, including 229E, NL63, OC43 and HKU1.
COVID-19 also differs from SARS-CoV, first reported in 2002, or MERS-CoV, first reported in 2012. However, genetic analyses have suggested that the COVID-19 may have emerged from a virus related to SARS.
Illness severity has varied, with reports ranging from very mild cases (including some with no reported symptoms) to severe cases resulting in death. Older adults, people who live in nursing homes or long-term care facilities and people with severe underlying health conditions or compromised immune systems reportedly are at higher risk of developing serious COVID-19 illness.